Novartis Pharmaceuticals Corp v. West-Ward Pharmaceuticals, No. 18-1434 (Fed. Cir. May 13, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

West-Ward Pharmaceuticals International Ltd (“West- Ward”)1 appeals the decision of the United States District Court for the District of Delaware holding that claims 1–3 of U.S. Patent No. 8,410,131 would not have been obvious in view of the prior art. We conclude that the district court did not err in its nonobviousness determination and affirm. BACKGROUND Novartis Pharmaceuticals Corp.